These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 17664922)
1. Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. Bagán J; Blade J; Cozar JM; Constela M; García Sanz R; Gómez Veiga F; Lahuerta JJ; Lluch A; Massuti B; Morote J; San Miguel JF; Solsona E Med Oral Patol Oral Cir Bucal; 2007 Aug; 12(4):E336-40. PubMed ID: 17664922 [No Abstract] [Full Text] [Related]
2. Expert panel recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaws. LDA J; 2005; 64(3):21-4. PubMed ID: 16639794 [No Abstract] [Full Text] [Related]
3. Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients--May 2006. Weitzman R; Sauter N; Eriksen EF; Tarassoff PG; Lacerna LV; Dias R; Altmeyer A; Csermak-Renner K; McGrath L; Lantwicki L; Hohneker JA Crit Rev Oncol Hematol; 2007 May; 62(2):148-52. PubMed ID: 17336086 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management. Ruggiero SL; Mehrotra B Annu Rev Med; 2009; 60():85-96. PubMed ID: 18928335 [TBL] [Abstract][Full Text] [Related]
5. [Osteonecrosis of the jaws during treatment with bisphosphonates: diagnosis and therapy]. Steiner B; Lenz JH; Gundlach KK; Freund M Dtsch Med Wochenschr; 2005 Sep; 130(38):2142-5. PubMed ID: 16172955 [No Abstract] [Full Text] [Related]
6. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment. Fehm T; Felsenberg D; Krimmel M; Solomayer E; Wallwiener D; Hadjii P Breast; 2009 Aug; 18(4):213-7. PubMed ID: 19651512 [TBL] [Abstract][Full Text] [Related]
7. [Bisphosphonates and osteonecrosis of the jaws]. Urade M Clin Calcium; 2007 Feb; 17(2):241-8. PubMed ID: 17272882 [TBL] [Abstract][Full Text] [Related]
8. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405 [TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates. King AE; Umland EM Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663 [TBL] [Abstract][Full Text] [Related]
10. Specialists play down risk of jaw condition. Stassen LF J Ir Dent Assoc; 2008; 54(4):153. PubMed ID: 18780680 [No Abstract] [Full Text] [Related]
11. Clinical guidelines for prevention of osteonecrosis of the jaws in patients in treatment with bisphosphonates: literature review and report of three cases. Sarzi Amadè D; Tallarico M; Loreti MC; Montecchi PP; Niccoli A Minerva Stomatol; 2008 Sep; 57(9):429-46. PubMed ID: 18923378 [TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment. Dickinson M; Prince HM; Kirsa S; Zannettino A; Gibbs SD; Mileshkin L; O'Grady J; Seymour JF; Szer J; Horvath N; Joshua DE Intern Med J; 2009 May; 39(5):304-16. PubMed ID: 19220531 [TBL] [Abstract][Full Text] [Related]
13. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538 [TBL] [Abstract][Full Text] [Related]
14. Osteonecrosis of the jaw: a rare and devastating side effect of bisphosphonates. Ryan P; Saleh I; Stassen LF Postgrad Med J; 2009 Dec; 85(1010):674-7. PubMed ID: 20075406 [TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates and osteonecrosis of the jaw: proceedings of an international conference. Bilezikian JP; Grbic JT Ann N Y Acad Sci; 2011 Feb; 1218():1-2. PubMed ID: 21291476 [TBL] [Abstract][Full Text] [Related]
17. [Osteonecrosis of the jaw and bisphophonates in oncology]. Facon T; Bensadoun RJ; Blanc JL; Confavreux C; Gourmet R; Maes JM; Penel G; Vieillard MH; Woeller A Bull Cancer; 2008 Apr; 95(4):413-8. PubMed ID: 18495570 [TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jaw and bisphosphonates--putting the risk in perspective. Bolland M; Hay D; Grey A; Reid I; Cundy T N Z Med J; 2006 Dec; 119(1246):U2339. PubMed ID: 17151713 [TBL] [Abstract][Full Text] [Related]
19. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. Campisi G; Fedele S; Colella G; Lo Casto A; Fusco V J Rheumatol; 2009 Feb; 36(2):451-3; author reply 453. PubMed ID: 19208579 [No Abstract] [Full Text] [Related]
20. Bisphosphonates and osteonecrosis of the jaw. Sambrook P; Olver I; Goss A Aust Fam Physician; 2006 Oct; 35(10):801-3. PubMed ID: 17019456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]